TPST (STOCKS)
Tempest Therapeutics, Inc. Common Stock
$1.250000
-0.010000 (-0.79%)
Prev close: $1.260000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Matthew Angel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $18.51M
- Employees
- 5
- P/E (TTM)
- -0.20
- P/B (TTM)
- 21.99
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-2.53 | $-0.29 | -2.2444 | -785.85% |
|
Dec 2025 (Q4)
|
$-0.62 | $-0.63 | +0.0124 | +1.96% |
|
Sep 2025 (Q3)
|
$-0.79 | $-3.34 | +2.5454 | +76.31% |
|
Jun 2025 (Q2)
|
$-2.07 | $-2.66 | +0.5871 | +22.10% |
Financial Statements
| Nonoperating Income/Loss | $261.00K |
| Operating Income/Loss | -$43.36M |
| Income/Loss From Continuing Operations After Tax | -$43.10M |
| Income/Loss From Continuing Operations Before Tax | -$43.10M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$43.10M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$43.10M |
| Net Income/Loss Available To Common Stockholders, Basic | -$43.10M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$6.01 |
| Diluted Earnings Per Share | -$6.01 |
| Basic Average Shares | 19,427,137 |
| Diluted Average Shares | 19,427,137 |
| Assets | $10.75M |
| Current Assets | $2.45M |
| Prepaid Expenses | $638.00K |
| Other Current Assets | $1.81M |
| Noncurrent Assets | $8.30M |
| Fixed Assets | $545.00K |
| Other Non-current Assets | $7.76M |
| Liabilities | $9.93M |
| Current Liabilities | $3.31M |
| Accounts Payable | $585.00K |
| Wages | $325.00K |
| Other Current Liabilities | $2.40M |
| Noncurrent Liabilities | $6.62M |
| Equity | $822.00K |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $822.00K |
| Liabilities And Equity | $10.75M |
| Net Cash Flow From Operating Activities | -$26.38M |
| Net Cash Flow From Operating Activities, Continuing | -$26.38M |
| Net Cash Flow From Investing Activities | $19.71M |
| Net Cash Flow From Investing Activities, Continuing | $19.71M |
| Net Cash Flow From Financing Activities | $6.68M |
| Net Cash Flow From Financing Activities, Continuing | $6.68M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$43.10M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$43.10M |
| Other Comprehensive Income/Loss | $0.00 |